Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION-1: ACT-guided heparinization during open abdominal aortic aneurysm repair
NL-OMON22304Recruiting
- Sponsor
- Dijklander Ziekenhuis
- Start
- Mar 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of heparin and protamine in abdominal aortic aneurysm (AAA) and iliac artery aneurysm (IAA), sponsored by Dijklander Ziekenhuis. Primary endpoints: Combined incidence of thromboembolic complications and all-cause mortality and Bleeding complications. Started Mar 2020; status: recruiting.
02
Drugs
heparinprotamine
03
Conditions
abdominal aortic aneurysm (AAA)iliac artery aneurysm (IAA)
Beyond the preview
Go deeper on NL-OMON22304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22304.